Financials Dolby Laboratories, Inc.

Stocks

DLB

US25659T1079

Software

Market Closed - NYSE Other stock markets 16:00:03 2026-07-02 EDT			5-day change	1st Jan Change
51.15 ^USD	-2.74%		-4.37%	-20.35%

06-05	Dolby Laboratories, Inc. and NBCUniversal Announce Peacock Streams Telemundo's FIFA World Cup 2026 Spanish-Language Coverage in Dolby Vision and Dolby Atmos with Dolby AC-4	CI
06-04	Dolby Laboratories, Inc. Presents at 2026 Baird Global Consumer, Technology & Services Conference, Jun-04-2026 09:40 AM

Projected Income Statement: Dolby Laboratories, Inc.

Fiscal Period: September	2021	2022	2023	2024	2025	2026	2027	2028
Net sales ¹	1,281	1,254	1,300	1,274	1,349	1,406	1,464	1,546
Change	-	-2.14%	3.66%	-2%	5.92%	4.23%	4.13%	5.56%
EBITDA ¹	550.2	420.6	463.9	460.1	496.3	538.6	570.4	618.1
Change	-	-23.55%	10.28%	-0.81%	7.87%	8.53%	5.9%	8.36%
EBIT ¹	344.4	206.6	215.8	258.3	265	293.4	342.2	398.6
Change	-	-40.01%	4.43%	19.73%	2.57%	10.74%	16.62%	16.49%
Interest Paid	-0.479	-0.394	-	-	-	-	-	-
Earnings before Tax (EBT) ¹	354.5	215.3	250.1	312.5	303.5	330.4	380	436.5
Change	-	-39.27%	16.15%	24.97%	-2.88%	8.85%	15.02%	14.86%
Net income ¹	310.2	184.1	200.7	261.8	255	258.7	296.4	347.5
Change	-	-40.66%	9%	30.48%	-2.6%	1.44%	14.59%	17.22%
Announcement Date	11/16/21	11/17/22	11/16/23	11/19/24	11/18/25	-	-	-

¹USD in Million

Estimates

Fiscal Period: September	2021 Q3	2021 Q4	2022 Q1	2022 Q2	2022 Q3	2022 Q4	2023 Q1	2023 Q2	2023 Q3	2023 Q4	2024 Q1	2024 Q2	2024 Q3	2024 Q4	2025 Q1	2025 Q2	2025 Q3	2025 Q4	2026 Q1	2026 Q2	2026 Q3	2026 Q4	2027 Q1	2027 Q2	2027 Q3	2027 Q4	2028 Q1	2028 Q2
Net sales ¹	286.8	285	351.6	334.4	289.6	278.2	334.9	375.9	298.4	290.6	315.6	364.5	288.8	304.8	357	369.6	315.5	307	346.7	395.6	312	351.9	360.7	404.3	330	369.3	372.2	414.3
Change	-	-0.62%	23.37%	-4.91%	-13.39%	-3.93%	20.39%	12.23%	-20.62%	-2.62%	8.61%	15.51%	-20.77%	5.54%	17.12%	3.52%	-14.62%	-2.7%	12.92%	14.11%	-21.15%	12.82%	2.5%	12.07%	-18.36%	11.91%	0.78%	11.32%
EBITDA ¹	104.4	88.96	146.6	133	97.69	77.73	144.2	160.3	66.2	76.43	122.1	153.4	88.51	96.1	143.5	164.2	99.75	88.86	134	194.1	86.66	148.4	142.7	163.6	112.4	151.7	144.2	176
Change	-	-14.76%	64.81%	-9.31%	-26.53%	-20.43%	85.57%	11.11%	-58.69%	15.45%	59.73%	25.66%	-42.31%	8.58%	49.35%	14.38%	-39.24%	-10.92%	50.79%	44.86%	-55.35%	71.24%	-3.85%	14.65%	-31.28%	34.99%	-4.95%	22.04%
EBIT ¹	56.09	40.36	90.58	43.35	45.57	27.11	94.09	109.2	15.94	-3.494	66.22	109	36.78	46.35	79.88	107.8	47.64	29.68	62.16	112.9	31.6	86.71	72.73	127.1	72.36	65.85	-	-
Change	-	-28.04%	124.4%	-52.14%	5.11%	-40.51%	247.09%	16.09%	-85.41%	-121.93%	1,995.28%	64.55%	-66.24%	26.02%	72.33%	34.91%	-55.79%	-37.7%	109.46%	81.7%	-72.02%	174.39%	-16.12%	74.79%	-43.08%	-9%	-	-
Charge d'intérêts	-0.108	-0.119	-0.084	-0.087	-0.084	-0.139	-0.081	-0.034	-0.114	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Earnings before Tax (EBT) ¹	59.12	43.06	91.44	43.45	49.41	30.97	99.98	117.3	23.76	9.033	80.83	121.7	50.16	59.73	-	120.2	55.52	41.67	71.6	119.7	40.39	98.66	84.04	126	74.3	95.67	95.36	130.2
Change	-	-27.17%	112.37%	-52.48%	13.72%	-37.31%	222.79%	17.3%	-79.74%	-61.98%	794.86%	50.62%	-58.8%	19.08%	-	-	-53.83%	-24.94%	71.84%	67.17%	-66.26%	144.27%	-14.82%	49.91%	-41.03%	28.77%	-0.33%	36.57%
Net income ¹	54.62	44.19	80.01	36.72	39.6	27.76	79.38	95.7	16.4	9.186	66.98	97.83	38.44	58.57	-	91.79	46.07	49.33	53.33	94.92	31.84	78.61	65.55	98.2	57.71	74.98	75.93	103.7
Change	-	-19.1%	81.06%	-54.11%	7.83%	-29.9%	185.97%	20.56%	-82.86%	-43.98%	629.16%	46.06%	-60.7%	52.35%	-	-	-49.81%	7.08%	8.1%	77.99%	-66.45%	146.87%	-16.61%	49.81%	-41.24%	29.93%	1.28%	36.5%
Announcement Date	7/29/21	11/16/21	2/3/22	5/5/22	8/9/22	11/17/22	2/2/23	5/4/23	8/3/23	11/16/23	2/1/24	5/2/24	8/7/24	11/19/24	1/29/25	5/1/25	7/31/25	11/18/25	1/29/26	4/30/26	-	-	-	-	-	-	-	-

¹USD in Million

Estimates

Forecast Balance Sheet: Dolby Laboratories, Inc.

Fiscal Period: September	2021	2022	2023	2024	2025	2026	2027	2028
Net Debt	-1,272	-818	-	-	-	-	-	-
Change	-	35.69%	-	-	-	-	-	-
Announcement Date	11/16/21	11/17/22	11/16/23	11/19/24	11/18/25	-	-	-

Estimates

Cash Flow Forecast: Dolby Laboratories, Inc.

Fiscal Period: September	2021	2022	2023	2024	2025	2026	2027	2028
CAPEX ¹	54.45	47.93	-	-	36.35	27.69	28	28
Change	-	-11.98%	-	-	-	-23.82%	1.12%	0%
Free Cash Flow (FCF) ¹	393.3	270.6	336.7	297.2	435.8	340.5	498.8	540.6
Change	-	-31.19%	24.42%	-11.73%	46.63%	-21.88%	46.48%	8.39%
Announcement Date	11/16/21	11/17/22	11/16/23	11/19/24	11/18/25	-	-	-

¹USD in Million

Estimates

Forecast Financial Ratios: Dolby Laboratories, Inc.

Fiscal Period: September	2021	2022	2023	2024	2025	2026	2027	2028
Profitability
EBITDA Margin (%)	42.94%	33.55%	35.69%	36.12%	36.79%	38.3%	38.95%	39.99%
EBIT Margin (%)	26.88%	16.48%	16.6%	20.28%	19.64%	20.86%	23.37%	25.79%
EBT Margin (%)	27.67%	17.17%	19.24%	24.53%	22.49%	23.49%	25.95%	28.24%
Net margin (%)	24.21%	14.68%	15.44%	20.56%	18.9%	18.4%	20.24%	22.48%
FCF margin (%)	30.7%	21.59%	25.91%	23.34%	32.31%	24.21%	34.06%	34.98%
FCF / Net Income (%)	126.78%	147.02%	167.82%	113.53%	170.91%	131.62%	168.26%	155.58%
Profitability
ROA	10.3%	11.04%	-	-	-	-	-	-
ROE	12.33%	13.21%	-	-	10%	3%	-	-
Financial Health
Leverage (Debt/EBITDA)	-	-	-	-	-	-	-	-
Debt / Free cash flow	-	-	-	-	-	-	-	-
Capital Intensity
CAPEX / Current Assets (%)	4.25%	3.82%	-	-	2.69%	1.97%	1.91%	1.81%
CAPEX / EBITDA (%)	9.9%	11.39%	-	-	7.32%	5.14%	4.91%	4.53%
CAPEX / FCF (%)	13.85%	17.71%	-	-	8.34%	8.13%	5.61%	5.18%
Items per share
Cash flow per share ¹	-	-	-	-	4.844	3.85	-	-
Change	-	-	-	-	-	-20.52%	-	-
Dividend per Share ¹	0.91	1.02	1.11	-	1.32	-	-	-
Change	-	12.09%	8.82%	-	-	-	-	-
Book Value Per Share ¹	25.7	23.43	-	-	27.36	28.17	-	-
Change	-	-8.86%	-	-	-	2.98%	-	-
EPS ¹	2.97	1.81	2.05	2.69	2.62	3.25	3.54	3.64
Change	-	-39.06%	13.26%	31.22%	-2.6%	24.05%	8.92%	2.82%
Nbr of stocks (in thousands)	101,387	97,677	95,641	95,348	95,844	94,598	94,598	94,598
Announcement Date	11/16/21	11/17/22	11/16/23	11/19/24	11/18/25	-	-	-